129 related articles for article (PubMed ID: 8154265)
1. PUVA treatment and choroidal malignant melanoma.
Haciyakupoğlu G; Varinli I; Memişoğlu HR; Varinli S; Demircan N; Denli G
Acta Ophthalmol (Copenh); 1993 Dec; 71(6):846-9. PubMed ID: 8154265
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
3. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
4. PUVA and cancer risk: the Swedish follow-up study.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
[TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma in a patient with severe psoriasis treated by oral methoxsalen photochemotherapy.
Frenk E
Dermatologica; 1983; 167(3):152-4. PubMed ID: 6414855
[No Abstract] [Full Text] [Related]
6. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
[TBL] [Abstract][Full Text] [Related]
7. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
Lindelöf B
Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
[TBL] [Abstract][Full Text] [Related]
8. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma in situ in two patients treated with psoralens and ultraviolet A.
Marx JL; Auerbach R; Possick P; Myrow R; Gladstein AH; Kopf AW
J Am Acad Dermatol; 1983 Dec; 9(6):904-11. PubMed ID: 6643789
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
Dayal S; ; Jain VK
Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
12. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. A case report and the experience of the PUVA Follow-up Study.
Gupta AK; Stern RS; Swanson NA; Anderson TF
J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):67-76. PubMed ID: 3403747
[TBL] [Abstract][Full Text] [Related]
14. Melanoma after PUVA therapy for psoriasis.
Whitmore SE; Morison WL
N Engl J Med; 1997 Aug; 337(7):502-3. PubMed ID: 9254340
[No Abstract] [Full Text] [Related]
15. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
16. Consensus workshop on the toxic effects of long-term PUVA therapy.
Morison WL; Baughman RD; Day RM; Forbes PD; Hoenigsmann H; Krueger GG; Lebwohl M; Lew R; Naldi L; Parrish JA; Piepkorn M; Stern RS; Weinstein GD; Whitmore SE
Arch Dermatol; 1998 May; 134(5):595-8. PubMed ID: 9606329
[TBL] [Abstract][Full Text] [Related]
17. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA).
Pariser DM; Wyles RJ
J Am Acad Dermatol; 1980 Sep; 3(3):248-50. PubMed ID: 7451691
[TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma after psoralen and ultraviolet A (PUVA) therapy.
Wolf P; Schöllnast R; Hofer A; Smolle J; Kerl H
Br J Dermatol; 1998 Jun; 138(6):1100-1. PubMed ID: 9747390
[No Abstract] [Full Text] [Related]
19. Cutaneous pigmented melanocytic tumor in a mouse treated with psoralen plus ultraviolet A radiation.
Alcalay J; Bucana C; Kripke ML
Photodermatol Photoimmunol Photomed; 1990 Feb; 7(1):28-31. PubMed ID: 2371167
[TBL] [Abstract][Full Text] [Related]
20. Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study.
Stern RS; Nichols KT
J Pediatr; 1996 Dec; 129(6):915-7. PubMed ID: 8969737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
